Interestingly, our recent study showed that the knockout of ATAD3A using Crispr/Cas9 genetic editing in the human liver cancer cell line HuH7 dramatically reduced levels of PINK1 [24], which suggests that ATAD3A interacts with PINK1 differently in different cells. The gene discussed is ATAD3A; the disease is liver cancer.